{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T23:25:18Z","timestamp":1788650718354,"version":"build-2803163510"},"reference-count":103,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,15]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Mycoplasma pneumoniae<\/jats:italic>\n                      (MP) infections occur in regional outbreaks every 3 to 7 years, lasting up to 2 years. Since this fall, there has been a significant rise in MP infections among children in China, indicating a regional epidemiological trend that imposes an increased national public health burden. To date, bibliometric methods have not been applied to studies on MP infection in children.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We searched for all relevant English publications on MP pneumonia in children published from 2011 to 2023 using Web of Science. Analytical software tools such as Citespace and VOSviewer were employed to analyze the collected literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>993 articles on MP pneumonia in children were published in 338 academic journals by 5062 authors affiliated with 1381 institutions across 75 countries\/regions. China led in global productivity with 56.19%. Among the top 10 prolific organizations, 8 were Chinese institutions, with Soochow University being the most active, followed by Capital Medical University and Zhejiang University. Zhimin Chen from Zhejiang University School of Medicine exhibited the highest H-index of 32. Keyword co-occurrence network analysis revealed 7 highly relevant clusters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The current research hotspots and frontiers in this field are primarily MP pneumonia, refractory MP pneumonia, lactate dehydrogenase, asthma, and biomarker. We anticipate that this work will provide novel insights for advancing scientific exploration and the clinical application of MP pneumonia in children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000037521","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T17:03:34Z","timestamp":1710522214000},"page":"e37521","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Research status and challenges of Mycoplasma pneumoniae pneumonia in children: A bibliometric and visualization analysis from 2011 to 2023"],"prefix":"10.1097","volume":"103","author":[{"given":"Congcong","family":"Liu","sequence":"first","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Ge","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binding","family":"Wang","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siman","family":"Li","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5842-2969","authenticated-orcid":false,"given":"Bohua","family":"Yan","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1147142","DOI":"10.3389\/fcimb.2023.1147142","article-title":"Rapid, ultrasensitive and highly specific diagnosis of Mycoplasma pneumoniae by a CRISPR-based detection platform.","volume":"13","author":"Zhou","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1590\/S1413-86702007000500012","article-title":"Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias.","volume":"11","author":"Vervloet","year":"2007","journal-title":"Braz J Infect Dis"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children.","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/s12879-022-07715-6","article-title":"Molecular beacon based real-time PCR p1 gene genotyping, macrolide resistance mutation detection and clinical characteristics analysis of Mycoplasma pneumoniae infections in children.","volume":"22","author":"Li","year":"2022","journal-title":"BMC Infect Dis"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1038\/s41467-021-25120-6","article-title":"Etiological and epidemiological features of acute respiratory infections in China.","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/crj.13620","article-title":"Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children.","volume":"17","author":"Fan","year":"2023","journal-title":"Clin Respir J"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/cid\/ciy419","article-title":"Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia.","volume":"68","author":"Kutty","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"e215840","DOI":"10.1001\/jamanetworkopen.2021.5840","article-title":"Bibliometric analysis of neurology articles published in general medicine journals.","volume":"4","author":"Wilson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fphar.2020.00037","article-title":"Quantitative analysis of the research literature.","volume":"11","author":"Yeung","year":"2020","journal-title":"Front Pharmacol"},{"key":"R10-20250503","first-page":"724","article-title":"CiteSpace II: visualization and knowledge discovery in bibliographic databases.","volume":"2005","author":"Synnestvedt","year":"2005","journal-title":"AMIA Annu Symp Proc"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fmicb.2016.00693","article-title":"Epidemiology of Mycoplasma pneumoniae infections in japan and therapeutic strategies for macrolide-resistant M pneumoniae.","volume":"7","author":"Yamazaki","year":"2016","journal-title":"Front Microbiol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1128\/JCM.00184-16","article-title":"Latest surveillance data on Mycoplasma pneumoniae infections in children, suggesting a new epidemic occurring in Beijing.","volume":"54","author":"Yan","year":"2016","journal-title":"J Clin Microbiol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1016\/S2666-5247(22)00190-2","article-title":"Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?","volume":"3","author":"Meyer Sauteur","year":"2022","journal-title":"Lancet Microbe"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"16569","DOI":"10.1073\/pnas.0507655102","article-title":"An index to quantify an individual\u2019s scientific research output.","volume":"102","author":"Hirsch","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.3390\/jcm11102824","article-title":"Refractory Mycoplasma pneumoniae pneumonia in children: early recognition and management.","volume":"11","author":"Tong","year":"2022","journal-title":"J Clin Med"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"e0156465","DOI":"10.1371\/journal.pone.0156465","article-title":"The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children.","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12916-017-0778-8","article-title":"Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects.","volume":"15","author":"Di Donato","year":"2017","journal-title":"BMC Med"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fmicb.2016.00157","article-title":"Mycoplasma pneumoniae epidemiology in England and Wales: a national perspective.","volume":"7","author":"Brown","year":"2016","journal-title":"Front Microbiol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12890-022-02047-2","article-title":"Development and validation of a nomogram to predict plastic bronchitis in children with refractory Mycoplasma pneumoniae pneumonia.","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Pulm Med"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1038\/s41598-021-86086-5","article-title":"Development of a scale for early prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children.","volume":"11","author":"Bi","year":"2021","journal-title":"Sci Rep"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ppul.24684","article-title":"Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children.","volume":"55","author":"Cheng","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"813614","DOI":"10.3389\/fped.2022.813614","article-title":"Development of a nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children.","volume":"10","author":"Shen","year":"2022","journal-title":"Front Pediatr"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12890-023-02684-1","article-title":"Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model.","volume":"23","author":"Li","year":"2023","journal-title":"BMC Pulm Med"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12887-020-02254-y","article-title":"The correlation between vitamin a status and refractory Mycoplasma Pneumoniae pneumonia (RMPP) incidence in children.","volume":"20","author":"Li","year":"2020","journal-title":"BMC Pediatr"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ppul.23095","article-title":"Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia.","volume":"50","author":"Guo","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"37037","DOI":"10.1038\/srep37037","article-title":"Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children.","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.21037\/tp-22-416","article-title":"Clinical analysis of the epidemiology and changes in inflammatory indexes of Mycoplasma pneumonia in acute and recovery stage pediatric patients.","volume":"11","author":"Liu","year":"2022","journal-title":"Transl Pediatr"},{"key":"R28-20250503","first-page":"765","article-title":"[Value of autotaxin in predicting refractory Mycoplasma pneumoniae pneumonia in children and its correlation with inflammatory cytokines].","volume":"24","author":"Fu","year":"2022","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1186\/s12879-021-06632-4","article-title":"Serum CXCL10\/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children.","volume":"21","author":"Li","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"766591","DOI":"10.3389\/fmicb.2021.766591","article-title":"Community-acquired respiratory distress syndrome toxin: unique exotoxin for M pneumoniae.","volume":"12","author":"Su","year":"2021","journal-title":"Front Microbiol"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s10020-019-0105-2","article-title":"High co-expression of TNF-\u03b1 and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia.","volume":"25","author":"Li","year":"2019","journal-title":"Mol Med"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"1054788","DOI":"10.3389\/fimmu.2022.1054788","article-title":"The CARDS toxin of Mycoplasma pneumoniae induces a positive feedback loop of type 1 immune response.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13052-019-0655-5","article-title":"The role of miR-29c\/B7-H3\/Th17 axis in children with Mycoplasma pneumoniae pneumonia.","volume":"45","author":"Li","year":"2019","journal-title":"Ital J Pediatr"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2478\/jtim-2018-0006","article-title":"Contemporary situation of community-acquired pneumonia in China: a systematic review.","volume":"6","author":"Zhu","year":"2018","journal-title":"J Transl Int Med"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1370\/afm.1993","article-title":"Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a meta-analysis.","volume":"14","author":"Marchello","year":"2016","journal-title":"Ann Fam Med"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/cid\/cix378","article-title":"Microorganisms associated with pneumonia in children <5 years of age in developing and emerging countries: the GABRIEL pneumonia multicenter, prospective, case-control study.","volume":"65","author":"B\u00e9net","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ijmm.2015.08.021","article-title":"New insights in the outbreak pattern of Mycoplasma pneumoniae.","volume":"305","author":"Jacobs","year":"2015","journal-title":"Int J Med Microbiol"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10096-010-0975-2","article-title":"Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods.","volume":"29","author":"Loens","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/14656566.2021.1882420","article-title":"Mycoplasma pneumoniae: a pathogen with unsolved therapeutic problems.","volume":"22","author":"Esposito","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.00090-09","article-title":"Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.","volume":"53","author":"Waites","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s40495-022-00297-6","article-title":"Lefamulin: a new hope in the field of community-acquired bacterial pneumonia.","volume":"8","author":"Adhikary","year":"2022","journal-title":"Curr Pharmacol Rep"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fmicb.2016.00205","article-title":"Potential molecular targets for narrow-spectrum agents to combat Mycoplasma pneumoniae infection and disease.","volume":"7","author":"Balish","year":"2016","journal-title":"Front Microbiol"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"882855","DOI":"10.3389\/fcimb.2022.882855","article-title":"Loop-mediated isothermal amplification coupled with nanoparticle-based biosensor: a rapid and sensitive method to detect Mycoplasma pneumoniae.","volume":"12","author":"Xiao","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12887-021-02523-4","article-title":"Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia.","volume":"21","author":"Tang","year":"2021","journal-title":"BMC Pediatr"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jmii.2013.03.015","article-title":"Comparison of real-time polymerase chain reaction and serological tests for the confirmation of Mycoplasma pneumoniae infection in children with clinical diagnosis of atypical pneumonia.","volume":"47","author":"Chang","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond.","volume":"30","author":"Waites","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"R47-20250503","first-page":"16","article-title":"Guidelines for the diagnosis and treatment of Mycoplasma pneumoniae pneumoniae in children (2023 edition).","volume":"20","year":"2023","journal-title":"Chin J Ration Drug Use"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/JCM.02913-13","article-title":"Comparison of the illumigene Mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae.","volume":"52","author":"Ratliff","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R49-20250503","first-page":"77","article-title":"Evaluation of a new real-time PCR assay for detection of Mycoplasma pneumoniae in clinical specimens.","volume":"25","author":"Zhao","year":"2012","journal-title":"Biomed Environ Sci"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.diagmicrobio.2013.07.016","article-title":"Real-time PCR detection of Mycoplasma pneumoniae in respiratory specimens.","volume":"77","author":"Schmitt","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fped.2019.00441","article-title":"Early diagnosis of Mycoplasma pneumoniae in children: Simultaneous Amplification and Testing (SAT) is the key.","volume":"7","author":"Li","year":"2019","journal-title":"Front Pediatr"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clinbiochem.2015.09.008","article-title":"Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.","volume":"49","author":"Agnello","year":"2016","journal-title":"Clin Biochem"},{"key":"R53-20250503","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/00365513.2020.1858491","article-title":"High ratio of C-reactive protein\/procalcitonin predicts Mycoplasma pneumoniae infection among adults hospitalized with community acquired pneumonia.","volume":"81","author":"Li","year":"2021","journal-title":"Scand J Clin Lab Invest"},{"key":"R54-20250503","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1515\/cclm-2019-0194","article-title":"A high C-reactive protein\/procalcitonin ratio predicts Mycoplasma pneumoniae infection.","volume":"57","author":"Neeser","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jmii.2021.09.010","article-title":"The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019-2020.","volume":"55","author":"Kuo","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.vaccine.2009.01.135","article-title":"Mycoplasma pneumoniae vaccine protective efficacy and adverse reactions--Systematic review and meta-analysis.","volume":"27","author":"Linchevski","year":"2009","journal-title":"Vaccine"},{"key":"R57-20250503","first-page":"e0171687","article-title":"Mycoplasma pneumoniae infections: pathogenesis and vaccine development.","volume":"12","author":"Jiang","year":"2017","journal-title":"Pathogens"},{"key":"R58-20250503","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.imlet.2018.03.006","article-title":"Live bacterial vaccine vector and delivery strategies of heterologous antigen: a review.","volume":"197","author":"Ding","year":"2018","journal-title":"Immunol Lett"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment.","volume":"7","author":"Pereyre","year":"2016","journal-title":"Front Microbiol"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.02060-12","article-title":"Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012.","volume":"57","author":"Zhao","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"e38585","DOI":"10.1371\/journal.pone.0038585","article-title":"The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel.","volume":"7","author":"Pereyre","year":"2012","journal-title":"PLoS One"},{"key":"R62-20250503","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1099\/jmm.0.000969","article-title":"Polyclonal spread of multiple genotypes of Mycoplasma pneumoniae in semi-closed settings in Yamagata, Japan.","volume":"68","author":"Suzuki","year":"2019","journal-title":"J Med Microbiol"},{"key":"R63-20250503","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3201\/eid2410.171194","article-title":"Multilocus sequence typing of Mycoplasma pneumoniae, Japan, 2002\u20132016.","volume":"24","author":"Ando","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"R64-20250503","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3201\/eid2408.180081","article-title":"Clonal expansion of macrolide-resistant sequence type 3 Mycoplasma pneumoniae, South Korea.","volume":"24","author":"Lee","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"R65-20250503","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia.","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R66-20250503","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmii.2018.09.009","article-title":"Mycoplasma pneumoniae in pediatric patients: do macrolide-resistance and\/or delayed treatment matter?","volume":"52","author":"Yang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"R67-20250503","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","article-title":"Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.","volume":"50","author":"Suzuki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R68-20250503","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","article-title":"A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.","volume":"15","author":"Matsubara","year":"2009","journal-title":"J Infect Chemother"},{"key":"R69-20250503","doi-asserted-by":"crossref","first-page":"e0324520","DOI":"10.1128\/JCM.03245-20","article-title":"Clinical evaluation of a novel point-of-care assay to detect Mycoplasma pneumoniae and associated macrolide-resistant mutations.","volume":"59","author":"Kakiuchi","year":"2021","journal-title":"J Clin Microbiol"},{"key":"R70-20250503","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1099\/jmm.0.001264","article-title":"Evaluation of GENECUBE Mycoplasma for the detection of macrolide-resistant Mycoplasma pneumoniae.","volume":"69","author":"Morinaga","year":"2020","journal-title":"J Med Microbiol"},{"key":"R71-20250503","doi-asserted-by":"crossref","first-page":"383.e5","DOI":"10.1016\/j.cmi.2018.10.006","article-title":"Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients.","volume":"25","author":"Wagner","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R72-20250503","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3892\/mmr.2021.12401","article-title":"Ribosomal RNA-depleted RNA sequencing reveals the pathogenesis of refractory Mycoplasma pneumoniae pneumonia in children.","volume":"24","author":"Huang","year":"2021","journal-title":"Mol Med Rep"},{"key":"R73-20250503","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fmicb.2016.00232","article-title":"The evolution of advanced molecular diagnostics for the detection and characterization of Mycoplasma pneumoniae.","volume":"7","author":"Diaz","year":"2016","journal-title":"Front Microbiol"},{"key":"R74-20250503","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1038\/s41598-017-08861-7","article-title":"Mycoplasma pneumoniae-associated bronchiolitis obliterans following acute bronchiolitis.","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci Rep"},{"key":"R75-20250503","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1038\/s41598-022-09700-0","article-title":"Intestinal bacteria flora changes in patients with Mycoplasma pneumoniae pneumonia with or without wheezing.","volume":"12","author":"Jiang","year":"2022","journal-title":"Sci Rep"},{"key":"R76-20250503","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13148-023-01430-y","article-title":"Azithromycin attenuates wheezing after pulmonary inflammation through inhibiting histone H3K27me3 hypermethylation mediated by EZH2.","volume":"15","author":"Wu","year":"2023","journal-title":"Clin Epigenetics"},{"key":"R77-20250503","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1183\/13993003.00152-2016","article-title":"Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.","volume":"48","author":"Hasegawa","year":"2016","journal-title":"Eur Respir J"},{"key":"R78-20250503","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/INF.0000000000001500","article-title":"Nasal airway microbiota profile and severe bronchiolitis in infants: a case-control study.","volume":"36","author":"Hasegawa","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R79-20250503","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41426-018-0097-y","article-title":"The concordance between upper and lower respiratory microbiota in children with Mycoplasma pneumoniae pneumonia.","volume":"7","author":"Dai","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"R80-20250503","doi-asserted-by":"crossref","first-page":"2202272","DOI":"10.1080\/22221751.2023.2202272","article-title":"Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia.","volume":"12","author":"Wang","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"R81-20250503","doi-asserted-by":"crossref","first-page":"ftaa074","DOI":"10.1093\/femspd\/ftaa074","article-title":"Chlamydia pneumoniae and Mycoplasma pneumoniae in children with cystic fibrosis: impact on bacterial respiratory microbiota diversity.","volume":"79","author":"Pittet","year":"2021","journal-title":"Pathog Dis"},{"key":"R82-20250503","first-page":"211","article-title":"[Mixed infections in children with Mycoplasma pneumoniae pneumonia].","volume":"50","author":"Chen","year":"2012","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"R83-20250503","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1017\/S0950268818000778","article-title":"Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia.","volume":"146","author":"Zhang","year":"2018","journal-title":"Epidemiol Infect"},{"key":"R84-20250503","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12879-020-05152-x","article-title":"Human adenovirus coinfection aggravates the severity of Mycoplasma pneumoniae pneumonia in children.","volume":"20","author":"Gao","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R85-20250503","first-page":"1033","article-title":"Clinical features of Mycoplasma pneumoniae pneumonia with adenovirus infection in children.","volume":"23","author":"Peng","year":"2021","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"R86-20250503","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4187\/respcare.03920","article-title":"Lactate dehydrogenase as a biomarker for prediction of refractory Mycoplasma pneumoniae pneumonia in children.","volume":"60","author":"Lu","year":"2015","journal-title":"Respir Care"},{"key":"R87-20250503","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3345\/kjp.2012.55.2.42","article-title":"Mycoplasma pneumoniae pneumonia in children.","volume":"55","author":"Youn","year":"2012","journal-title":"Korean J Pediatr"},{"key":"R88-20250503","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12985-022-01914-y","article-title":"Comprehensive virome analysis of the viral spectrum in paediatric patients diagnosed with Mycoplasma pneumoniae pneumonia.","volume":"19","author":"Guo","year":"2022","journal-title":"Virol J"},{"key":"R89-20250503","first-page":"911","article-title":"[Pathogenic characteristics of hospitalized severe acute respiratory infections in Shanghai, China, 2015-2017].","volume":"40","author":"Zheng","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"R90-20250503","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jaad.2014.06.026","article-title":"Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review.","volume":"72","author":"Canavan","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R91-20250503","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2332\/allergolint.11-OA-0309","article-title":"Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan.","volume":"60","author":"Kunimi","year":"2011","journal-title":"Allergol Int"},{"key":"R92-20250503","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/pde.13140","article-title":"Mucositis secondary to chlamydia pneumoniae infection: expanding the mycoplasma pneumoniae-induced rash and mucositis concept.","volume":"34","author":"Mayor-Ibarguren","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"R93-20250503","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1111\/j.1651-2227.2011.02342.x","article-title":"Severe Mycoplasma pneumoniae-associated mucositis treated with immunoglobulins.","volume":"100","author":"Bressan","year":"2011","journal-title":"Acta Paediatr"},{"key":"R94-20250503","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamadermatol.2019.3602","article-title":"Frequency and clinical presentation of mucocutaneous disease due to Mycoplasma pneumoniae infection in children with community-acquired pneumonia.","volume":"156","author":"Meyer Sauteur","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R95-20250503","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0255-0857.174112","article-title":"Pathogenesis of Mycoplasma pneumoniae: an update.","volume":"34","author":"Chaudhry","year":"2016","journal-title":"Indian J Med Microbiol"},{"key":"R96-20250503","doi-asserted-by":"crossref","first-page":"823376","DOI":"10.3389\/fped.2022.823376","article-title":"Case report and literature review: clinical characteristics of 10 children with Mycoplasma pneumoniae-induced rash and mucositis.","volume":"10","author":"Chen","year":"2022","journal-title":"Front Pediatr"},{"key":"R97-20250503","first-page":"490","article-title":"Increased total serum immunoglobulin E in children developing Mycoplasma pneumoniae-related extra-pulmonary diseases.","volume":"17","author":"Poddighe","year":"2018","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"R98-20250503","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/BOR.0000000000000494","article-title":"Extra-pulmonary diseases related to Mycoplasma pneumoniae in children: recent insights into the pathogenesis.","volume":"30","author":"Poddighe","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"R99-20250503","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.2147\/JPR.S428991","article-title":"Bibliometric and visualization analysis of biomechanical research on lumbar intervertebral disc.","volume":"16","author":"Hou","year":"2023","journal-title":"J Pain Res"},{"key":"R100-20250503","doi-asserted-by":"crossref","first-page":"e34002","DOI":"10.1097\/MD.0000000000034002","article-title":"Global research hotspots and frontiers of myasthenia gravis from 2002 to 2021: a bibliometric study.","volume":"102","author":"Yang","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R101-20250503","doi-asserted-by":"crossref","first-page":"1243151","DOI":"10.3389\/fnins.2023.1243151","article-title":"Research hotspots and trends of brain-computer interface technology in stroke: a bibliometric study and visualization analysis.","volume":"17","author":"Li","year":"2023","journal-title":"Front Neurosci"},{"key":"R102-20250503","doi-asserted-by":"crossref","first-page":"1055118","DOI":"10.3389\/fonc.2022.1055118","article-title":"Global trends and hotspots in research of robotic surgery in oncology: a bibliometric and visual analysis from 2002 to 2021.","volume":"12","author":"Lu","year":"2022","journal-title":"Front Oncol"},{"key":"R103-20250503","doi-asserted-by":"crossref","first-page":"1003228","DOI":"10.3389\/fphar.2022.1003228","article-title":"Hotspots and trends in multiple myeloma bone diseases: a bibliometric visualization analysis.","volume":"13","author":"Hou","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:04:35Z","timestamp":1746302675000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":103,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037521","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]}}}